Alan Edward Tomkinson
6Patents
2h-index
9Co-inventors
36Inventor score
Filing activity: Oct 9, 2009 → Jul 8, 2015
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9132120B1 | Targeting abnormal DNA repair in therapy-resistant breast and pancreatic cancers | Emerging Cross-Sectional Technologies | 3 | Active |
| US8445537B2 | Compounds that inhibit human DNA ligases and methods of treating cancer | Physics | 3 | Active |
| US9073896B2 | Compounds that inhibit human DNA ligases and methods of treating cancer | Physics | 1 | Active |
| US9757375B2 | Compounds that inhibit human DNA ligases and methods of treating cancer | Physics | 0 | Active |
| US10086010B2 | Synergistic enhancement of 5-fluorouracil cytotoxicity by deoxyuridine analogs in cancer cells | Human Necessities | 0 | Active |
| US9623008B2 | Targeting abnormal DNA repair in therapy-resistant breast and pancreatic cancers | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.